Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
D. Crowder & W. P. Maclay. (1984) Pizotif en once daily in the prophylaxis of migraine: results of a multi-centre general practice study. Current Medical Research and Opinion 9:4, pages 280-285.
Read now
Read now
Articles from other publishers (23)
Paulo Sergio Faro Santos, Eliana Meire Melhado, Alexandre Ottoni Kaup, Aline Turbino Neves Martins da Costa, Célia Aparecida de Paula Roesler, Élcio Juliato Piovesan, Elder Machado Sarmento, Giselle Oliveira Martins Theotonio, Henrique Carneiro de Campos, Ida Fortini, Jano Alves de Souza, Jayme Antunes Maciel Júnior, João Batista Alves Segundo, João José Freitas de Carvalho, José Geraldo Speziali, Leandro Cortoni Calia, Liselotte Menke Barea, Luiz Paulo Queiroz, Marcio Nattan Portes Souza, Marcos Ravi Cerqueira Ferreira Figueiredo, Maria Eduarda Nobre de Magalhães Costa, Mário Fernando Prieto Peres, Mauro Eduardo Jurno, Patrícia Machado Peixoto, Pedro André Kowacs, Pedro Augusto Sampaio Rocha-Filho, Pedro Ferreira Moreira Filho, Raimundo Pereira Silva-Neto & Yara Dadalti Fragoso. (2022) Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II. Arquivos de Neuro-Psiquiatria 80:09, pages 953-969.
Crossref
Crossref
Yara Dadalti Fragoso, Giullia C. Mangas Lopes, Giovanna Marcilio Santos, Paula Carturan & Ana Luiza C. Martimbianco. (2021) Pizotifen for the treatment of migraine. A systematic review and meta-analysis. Headache Medicine 12:3, pages 168-181.
Crossref
Crossref
Jill C. Rau & David W. Dodick. (2019) Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists. Current Treatment Options in Neurology 21:4.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
223
239
.
Rubesh Gooriah, Randa Nimeri & Fayyaz Ahmed. (2015) Evidence-Based Treatments for Adults with Migraine. Pain Research and Treatment 2015, pages 1-13.
Crossref
Crossref
Jeffrey L. Jackson, Elizabeth Cogbill, Rafael Santana-Davila, Christina Eldredge, William Collier, Andrew Gradall, Neha Sehgal & Jessica Kuester. (2015) A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLOS ONE 10:7, pages e0130733.
Crossref
Crossref
. (2014) Canadian Headache Society Guideline for Migraine Prophylaxis: Supplement 2. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 39:S2, pages i-63.
Crossref
Crossref
Bénédicte Verdu, Isabelle Decosterd, Thierry Buclin, Friedrich Stiefel & Alexandre Berney. (2008) Antidepressants for the Treatment of Chronic Pain. Drugs 68:18, pages 2611-2632.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Joanne Moore. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
5
.
SD Silberstein & PJ Goadsby. (2016) Migraine: Preventive Treatment. Cephalalgia 22:7, pages 491-512.
Crossref
Crossref
Glen E Tomkins, Jeffrey L Jackson, Patrick G O’Malley, Erin Balden & James E Santoro. (2001) Treatment of chronic headache with antidepressants: a meta-analysis11Disclaimer: The views in this article reflect those of the authors and are not intended to represent in any way those of the U.S. Army or the Department of Defense.. The American Journal of Medicine 111:1, pages 54-63.
Crossref
Crossref
NM Ramadan, LL Schultz & SJ Gilkey. (2016) Migraine Prophylactic Drugs. Cephalalgia 17:2, pages 73-80.
Crossref
Crossref
D. Soyka. (1987) Migränetherapie-aktueller Stand und PerspektivenTherapy for migraine-the current state of the art and perspectives. Der Schmerz 1:2, pages 92-101.
Crossref
Crossref
H Havanka-Kanniainen, E Hokkanen & V V Myllylä. (2016) Efficacy of Nimodipine in Comparison with Pizotifen in the Prophylaxis of Migraine. Cephalalgia 7:1, pages 7-13.
Crossref
Crossref
David NK Symon & George Russell. (2016) Abdominal Migraine: A Childhood Syndrome Defined. Cephalalgia 6:4, pages 223-228.
Crossref
Crossref
Rosanna Cerbo, Massimo Casacchia, Rita Formisano, Massimo Feliciani, Giuliana Cusimano, Maria Gabriella Buzzi & Alessandro Agnoli. (2016) Flunarizine-Pizotifen Single-Dose Double-Blind Cross-Over Trial in Migraine Prophylaxis. Cephalalgia 6:1, pages 15-18.
Crossref
Crossref
Steinar Vilming, Brit Standnes & Christer Hedman. (2016) Metoprolol and Pizotifen in The Prophylactic Treatment of Classical and Common Migraine. A Double-Blind Investigation. Cephalalgia 5:1, pages 17-23.
Crossref
Crossref
P. Louis & E. L. H. Spierings. (2016) Comparison of Flunarizine (Sibelium®) and Pizotifen (Sandomigran®) in Migraine Treatment: A Double-Blind Study. Cephalalgia 2:4, pages 197-203.
Crossref
Crossref
P. O. Behan. (1982) Pizotifen in the Treatment of Severe Recurrent Headache Single and divided dose therapy compared. International Journal of Clinical Practice 36:1, pages 13-17.
Crossref
Crossref
S Mazal & E A Rachmilewitz. (1980) The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients.. Journal of Neurology, Neurosurgery & Psychiatry 43:12, pages 1137-1140.
Crossref
Crossref